Cambridge Investment Research Advisors »

Rigel Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $266k 6.2k 42.91

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Rigel Pharmaceuticals

BlackRock
State Street Corporation
Vanguard Group
Armistice Capital
Goldman Sachs Group
Marshall Wace
Capitolis Liquid Global Markets
LSV Asset Management
Renaissance Technologies
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jane Street
D. E. Shaw & Co
Soleus Capital Management

View all funds holding Rigel Pharmaceuticals